tirzepatide vs semaglutide español Tirzepatide, which is better for you? Semaglutide vs Tirzepatide: Compare Diabetes
Description
Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial
This feature helps reduce the risk of low blood sugar, known as hypoglycemia
This information helps your healthcare provider adjust your treatment plan
Once-weekly subcutaneous injection
In head-to-head trials, tirzepatide demonstrated greater efficacy in glycemic control and weight reduction compared to semaglutide 1 mg (SURPASS-2)
Improved Cardiovascular Outcomes : Reduction in risk factors such as weight, blood pressure, and lipids
